Marina Malikova, PhD, MSci, MACI, MBA, RAC Hear my name
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Surgery

PhD, Russian Academy of Sciences
MA, Boston University School of Medicine
MSc, Voronezh State University



Dr. Malikova graduated from the Institute of Biochemistry, Russian Academy of Science, in Moscow, Russia with a PhD in Biochemistry. She has a strong background in biomedical sciences and has completed her postdoctoral fellowship in the field of cell signaling and cell migration. She also holds a Master’s Degree in Clinical Investigation and Project Management Certification from Boston University.

In her current role as Executive Director, Dr. Malikova manages research efforts in seven divisions of the Department of Surgery at Boston Medical Center. She is responsible for clinical trials and basic biomedical research operations, risk management, strategic planning, and macro-management of research programs. She provides guidance and oversight to the Project Managers, Clinical Research Associates (CRAs), Clinical Research Coordinators (CRCs), and laboratory staff. She also provides assistance to investigators with protocol and informed consent writing, regulatory submissions, clinical trial agreements and budget development.

Executive Director
Boston University Chobanian & Avedisian School of Medicine
Surgical Translational Research Operations and Compliance


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Lotfollahzadeh S, Paul H, Bonifacio J, Almiron R, Hockestra I, Przekop K, Yamamoto T, Piqueras MC, Yin W, Sethuraman K, Jose A, Malikova M, Siracuse JJ, Belghasem M, Cabral H, Sayed N, Chitalia V. A Murine Model of Cardiovascular-Kidney-Metabolic Syndrome Demonstrates Compromised Limb Function in the Ischemic Hind Limb. Kidney360. 2025 Oct 13.View Related Profiles. PMID: 41082313; DOI: 10.34067/KID.0000000900;
     
  2. Schneider AC, Cilley KN, Malikova MA. Impact of social determinants of health on safety of patients in device clinical trials conducted at a safety-net hospital. Ther Adv Drug Saf. 2025; 16:20420986251349005. PMID: 41084611; PMCID: PMC12515286; DOI: 10.1177/20420986251349005;
     
  3. Cilley KN, Kaliaev AO, Malikova MA. Impact of Protocol Amendments, Personnel Experience and Social Determinants of Health on Study Protocol Adherence in Clinical Trials with Combination Products. Ther Innov Regul Sci. 2025 Aug 16. PMID: 40819154; DOI: 10.1007/s43441-025-00859-y;
     
  4. Joyce NP, Coker D, Volansky V, Malikova MA. Risk-based safety and quality management strategies in wound care trials at a tertiary, safety net hospital. J Wound Care. 2025 May 01; 34(Sup5):S34-S44.View Related Profiles. PMID: 40358500
     
  5. Joyce NP, Vazirani A, Roddy C, Malikova MA. Effect of social determinants of health on clinical trials conducted for diabetic foot ulcer and venous leg ulcer at a safety net hospital. Wounds. 2025 Apr; 37(4):158-165. PMID: 40368391; DOI: 10.25270/wnds/24089;
     
  6. He Y, Wei G, Greene T, Imrey PB, Northrup H, Radeva MK, Beck GJ, Gassman JJ, Kraiss LW, Robbin M, Roy-Chaudhury P, Cheung AK, Berceli SA, Shiu YT. Hemodynamics are associated with subsequent lumen remodeling and clinical maturation of hemodialysis arteriovenous fistula. Sci Rep. 2025 Feb 19; 15(1):6131. PMID: 39972115; PMCID: PMC11840087; DOI: 10.1038/s41598-025-89896-z;
     
  7. Lotfollahzadeh S, Vazirani A, Sellinger IE, Clovie J, Hoekstra I, Patel A, Malloum AB, Yin W, Paul H, Yadati P, Siracus J, Malikova M, Pernar LI, Francis J, Stern L, Chitalia VC. Aryl Hydrocarbon Receptor Pathway Augments Peritoneal Fibrosis in a Murine CKD Model Exposed to Peritoneal Dialysate. Kidney360. 2024 Sep 01; 5(9):1238-1250.View Related Profiles. PMID: 39235862; PMCID: PMC11441816; DOI: 10.34067/KID.0000000000000516;
     
  8. Bathla T, Lotfollahzadeh S, Quisel M, Mehta M, Malikova M, Chitalia VC. End Organ Affection in Sickle Cell Disease. Cells. 2024 May 29; 13(11).View Related Profiles. PMID: 38891066; PMCID: PMC11174153; DOI: 10.3390/cells13110934;
     
  9. Kugener V, Palin K, Salas M, Webster P, Cole A, Price J, Habibi S, Naboulet C, Ely D, Joshi P, Malikova MA. The American Program in Pharmacovigilance (Am2P): a new accredited online training program in pharmacovigilance and pharmacoepidemiology. Ther Adv Drug Saf. 2024; 15:20420986241249905. PMID: 38737826; PMCID: PMC11088298; DOI: 10.1177/20420986241249905;
     
  10. Cheng TW, Doros G, Jones DW, Vazirani A, Malikova MA. Evaluation of Computerized Tomography Utilization in Comparison to Digital Subtraction Angiography in Patients with Peripheral Arterial Disease. Ann Vasc Surg. 2024 Oct; 107:214-228.View Related Profiles. PMID: 38582215
     
Showing 10 of 92 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 82 publications over 20 distinct years, with a maximum of 9 publications in 2023

YearPublications
20012
20021
20041
20071
20092
20102
20111
20133
20143
20157
20164
20178
20187
20196
20203
20214
20228
20239
20244
20256


2015 BU BEST Mentoring Circle: Valued Mentor Award
2005-2006 NIH: Travel Award
2001 International Union of Biochemistry and Molecular Biology: Travel Award
Contact for Mentoring:

88 E. Newton St Newton Pavilion
Boston MA 02118
Google Map

(617) 414-6835 (fax)

Malikova's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department